VASOInnovations is a company that designs medical devices with a focus on improving life. Their flagship product is the VASOBand, which is the only FDA-cleared patent hemostasis device capable of concomitant ipsilateral ulnar compression. This device is recommended by the Society of Cardiovascular and Angiography Interventions to maximize radial artery patency.

The VASOBand offers several advantages:

Reduces Radial Artery Occlusion: Clinically proven to reduce the rate of Radial Artery Occlusion from 10.2% to 1.6%.
Faster Patient Recovery: Less time needed to manage and monitor patients post-op, meaning patients go home sooner.
Achieves Patent Hemostasis: Clinically proven to achieve patent hemostasis 97% of the time.
No Workflow Changes: Keeps it simple for all care teams.
Reduces Rebound Bleeding: Clinically proven to reduce incidence of rebound bleeding from 8.7% to 1.6%.
Easy to Use: No additional training – ready to be used on Day 1.
Reduces Hematoma:Clinically proven to reduce hematoma from 6.3% to 0.8%.
High Patient Comfort: Wider band design provides high patient comfort compared with competing devices.

VASOInnovations encourages anyone with questions to contact them for more information.